| Report ID | 242247 |
| Drug Identification Number | 02475723 |
| Brand name | GLN-OLMESARTAN HCTZ |
| Common or Proper name | OLMESARTAN HCTZ |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
| Strength(s) | 25MG 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 tablets |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-11-01 |
| Actual start date | 2025-11-01 |
| Estimated end date | 2026-03-14 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-03 |
| Company comments | Product is on backorder |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v30 | 2026-03-03 | French | Compare |
| v29 | 2026-03-03 | English | Compare |
| v28 | 2026-03-03 | French | Compare |
| v27 | 2026-03-03 | English | Compare |
| v26 | 2026-02-13 | French | Compare |
| v25 | 2026-02-13 | English | Compare |
| v24 | 2026-02-13 | French | Compare |
| v23 | 2026-02-13 | English | Compare |
| v22 | 2025-12-09 | French | Compare |
| v21 | 2025-12-09 | English | Compare |
| v20 | 2025-06-20 | French | Compare |
| v19 | 2025-06-20 | English | Compare |
| v18 | 2025-06-11 | French | Compare |
| v17 | 2025-06-11 | English | Compare |
| v16 | 2025-05-15 | French | Compare |
| v15 | 2025-05-15 | English | Compare |
| v14 | 2025-02-11 | French | Compare |
| v13 | 2025-02-11 | English | Compare |
| v12 | 2025-01-17 | French | Compare |
| v11 | 2025-01-17 | English | Compare |